RESULTS OF TRAIL 2017 CALLS

7 new emerging projects:

NEMHO, NanoEmulsion for Magnetic Hyperthermia in Oncology (Sylvie Crauste-Manciet, EA IMOTION);

WHOBO-MP2RAGE, Whole body ultra-fast 3D T1 mapping with non-cartesian MP2RAGE sequences (Emeline Ribot, Aurélien Trotier, RMSB);

INNOVATHER, Innovative ways to enhance radiopharmaceutical therapy (Clément Morgat, INCIA);

MEMIM, Multiphoton endomicroscopy for metabolic imaging of macrophages in atherosclerosis (Gisèle Clofent-Sanchez, RMSB);

DIFFIR, Ex vivo DIFFusion-weighted MRI of renal Ischemia Reperfusion injury (Souleymane Maïga, EA IMOTION);

BRAIN-RESV, Neuroprotective effect of resveratrol in hypoxic ischemic rat pups: how supplementation of the pregnant female could impact brain lesion of the pups ? (Anne-Karine Bouzier-Sore, RMSB);

DEEP STROKE, DEEP Learning for prediction of long-term motor impairment after STROKE (Thomas Tourdias, U1215)

2 consolidated projects:

BIOPSYPROSTAPROBE (post-doc and open program)

TBI (post-doc program)

The TRAIL research portfolio is now composed of 41 research projects (see here)